Wie hoch ist der Preis für BillionToOne, Inc. (BLLN)

Preis für BillionToOne, Inc. (BLLN) ist $99.89

Wie hoch ist die Marktkapitalisierung für BillionToOne, Inc. (BLLN)

Marktkapitalisierung für BillionToOne, Inc. (BLLN) ist $4.59B

BillionToOne, Inc. (BLLN) KUV

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Jahr	P/S-Verhältnis	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

P/S-Verhältnis

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	P/S-Verhältnis	P/S-Verhältnis-Differenz	Land
Thermo Fisher Scientific Inc. TMO.US	4.72	-	US
Danaher Corporation DHR.US	5.67	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	16.40	-	US
Agilent Technologies, Inc. A.US	5.80	-	US

Unternehmen

P/S-Verhältnis

P/S-Verhältnis-Differenz

Land